Associate Scientist

Senior Analytical Scientist I

Cell Therapy Specialist II 

Clinical Trial Manager

Senior Clinical Trial Manager 

Senior Manager, Corporate Communications and Digital Media

Director, Clinical Data Management 

Associate Director, Supply Chain Operations

Procurement Manager

Principal Scientist, Translational Sciences

Director, Clinical Regulatory Affairs

Associate Director, Biostatistics

Senior Scientist, Machine Learning and Protein Design

Director, Pipeline Strategy 

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

A-Alpha Bio

A2 Biotherapeutics

AAVogen

ACELYRIN

AI Proteins

AIRNA Bio

ALX Oncology

AN2 Therapeutics

AOA Dx

ARTBIO

AUM BioTech

AVROBIO

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

Acepodia

Achieve Life Sciences

Acomhal Research

Acrivon Therapeutics

Actym Therapeutics, Inc.

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

Admera Health

Adverum Biotechnologies

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agastiya Biotech

Agena Bioscience

AiViva Biopharma

Ainnocence

AivoCode

Aixa Bio

Akero Therapeutics

Akita Biosciences

Akouos

Alamar Biosciences

Alector

Alida Biosciences

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Oncology

Alphabioregen

Alpine Immune Sciences

AltPep

Alterome Therapeutics

Altis Biosystems

Alto Neuroscience

Alumis

Alveo Technologies

Alveolus Bio

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AnHeart Therapeutics

Anagram Therapeutics

Ancora Biotech LLC

Andes

Andson Biotech

Anebulo Pharmaceuticals

Angiex

Angiocrine Bioscience

Anima Biotech

Ankyra

Annexon Biosciences

Anodyne Nanotech

Anokion

Ansa Biotechnologies

Antheia

Anthos Therapeutics

Apaxon Biotech LLC

Arcellx is developing immunotherapies to treat cancer. Chimeric antigen receptor (CAR) T-cells are the latest innovation to identify and eliminate cancer cells, yet there is still more room for improvement. Arcellx’s unique approach involves their novel D-Domain technology, a small, stable, fully synthetic binding agent that can be combined with CARs to improve target specificity and enhance binding affinity. From the D-Domain, Arcellx can generate diverse libraries of proprietary target-binding domains which serve as the foundation of their proprietary ddCAR and ARC-SparX platforms. Arcellx is currently developing cell therapies treatments for multiple myeloma, acute myeloid leukemia and solid tumors, the first of which is now in Phase 2 clinical trials.

<p>Arcellx is developing immunotherapies to treat cancer. Chimeric antigen receptor (CAR) T-cells are the latest innovation to identify and eliminate cancer cells, yet there is still more room for improvement. Arcellx’s unique approach involves their novel D-Domain technology, a small, stable, fully synthetic binding agent that can be combined with CARs to improve target specificity and enhance binding affinity. From the D-Domain, Arcellx can generate diverse libraries of proprietary target-binding domains which serve as the foundation of their proprietary ddCAR and ARC-SparX platforms. Arcellx is currently developing cell therapies treatments for multiple myeloma, acute myeloid leukemia and solid tumors, the first of which is now in Phase 2 clinical trials.</p>


Find a biotech startup job.